Abstract-The addition of lo-' M to M neomycin to incubations of subcellular fractions of guineapig cerebral cortex increased the labelling of phosphatidylinositol phosphate and decreased the labelling of phosphatidylinositol diphosphate by [y-3ZP]ATP. The effect was observed in all subcellular fractions tested and depended on the cationic form of the antibiotic. Similar effects on lipid labelling were exerted by related aminoglycosidic antibiotics. by neamine, spermine and poly-L-lysine. Other neomycin fragments. antibiotics, local anesthetics or small polyamines were ineffective. Neomycin also inhibited the enzymatic hydrolysis of 32P-polyphosphoinositides. The addition of the drug to aqueous dispersions of these lipids increased the turbidity and lowered the pH of the suspensions. It is suggested that the effects of neomycin on polyphosphoinositide metabolism result from the formation of an ionic complex between the lipids and the antibiotic.
AMINOGLYCOSIDE antibiotics-neomycin, streptomycin, and related compounds-are potent antibacterial agents, but also exert toxic actions on eukaryotic cells. These actions include block of neuromuscular and ganglionic transmission (PITTINGER & ADAMSON, 1972) , nephrotoxicity, and. most prominently, ototoxicity in the cochlea and the vestibular system (HAWWe have recently demonstrated (SCHACHT, 1974; ORSULAKOVA et al., 1976) that the incorporation of 32PI into polyphosphoinositides is altered in inner ear tissues of guinea pigs receiving chronic ototoxic doses of neomycin. In acute experiments with cochlear perfusions we have shown that the change of polyphosphoinositide labelling followed the same dose response as the decrease of cochlear microphonic potential (NUTTALL et a/., 1975) . Although a physiological role for the polyphosphoinositides (phosphatidylinositol phosphate and phosphatidylinositol diphosphate) has not yet been established, there are strong indications that they are involved in the control of membrane permeability in bioelectric events (MICHELL, 1975) . Of all tissues, brain has the highest content of polyphosphoinositides (HAUSER & EICH- BERG, 1973 ) and provides a convenient system to study their metabolism. We therefore investigated the mechanism of neomycin action o n the turnover of phosphatidylinositol phosphate and phosphatidylinositol diphosphate in subcellular fractions of guinea-pig cerebral cortex in uitro. KINS, 1970) .
Ahbreviutiom used in tables and figures: PhA. phosphatidic acid (1.2-diacyl-sn-glycero-3-phosphate); PhI. PhIP, PhIP,. phosphatidylinositol, phosphate. diphosphate; Nm. Neomycin B.
MATERIALS AND METHODS
Cerebral cortex from albino guinea-pigs was homogenized in 0.32 M-sucrose in a Teflon-glass homogenizer to yield a 10% homogenate (w/v). This was centrifuged for 10min at l000g and washed once. The combined supernatant fractions were centrifuged for 20 min at 13,000 g to yield a crude nerve ending-mitochondria1 pellet and a supernatant fraction containing cytosol and microsomes. The nerve ending-mitochondria1 pellet was suspended in 30 ml of 0.32 M-sucrose, and was layered over three tubes of a discontinuous gradient consisting of 13 ml each of 0.8-and 1.2~-sucrose, which was centrifuged in an SW 27 rotor for 120 min at 62,000 g. Fractions collected at the interfaces were a myelin-rich fraction over 0.8 M-SUCrose, a nerve ending-rich fraction over 1.2 M-sucrose and a pellet containing mitochondria. The fractions were pelleted by centrifuging for 30min at 100,OOOg. Each pellet was suspended in 0.16 M-sucrose/S mM-Tris-Cl (pH 7.4) and frozen twice in a dry-ice-acetone bath and thawed.
For lipid labelling, incubations were performed at 37°C in air with shaking. The fractions were incubated for 15 min with 40 mM-Tris-CI (pH 7.4) and 10 m-dithioerythritol, in the presence or absence of drugs; all in a volume of 0.25 ml. Then were added (final concentrations) 80 mM-Tris-Cl (pH 7.4). 20 mM-MgCI,, 0.2 mM-EDTA, and 4 m~-[y-~'p]ATp; final volume, 0.5 ml. The incubations were terminated by the addition of 1.5 ml of chloroformmethanol ( I :2, v/v). After addition of 0.5 ml 2.4 N-HCI and 1.0 ml of chloroform, mixing and centrifugation, the lower phase was collected and the upper phase was reextracted with 1.0 ml of chloroform. Samples of the remaining upper phase were analyzed for C3'P]ATP (HUANG, 1970) . The combined lower phases were washed with 2.0ml of methanolM5 N-HCI (2:3, v/v) and the upper layer was discarded. Maintainance of high acidity in the upper phase during extraction and washing was necessary for complete recovery of polyphosphoinositides. Portions of the lower phase were removed for the determination of total 1119 lipid-"P. the rest was dried under N2. For TLC the lipids were taken up in a small volume of chloroform-methanolconc. HCI (6:3:0.1, by vol) and applied to TLC plates 'Silicagel 60' (E. Merck). Routinely. plates were developed in chloroform-methanol--aqueous conc. NH,-H20 (15:45:3.5: 1 I, by vol) which resulted in good separation of phosphatidylinositol phosphate. phosphatidylinositol diphosphate and phosphatidic acid. "P-lipids were located by autoradiography. scraped and counted by liquid scintillation. Lipid standards for identification were commercial (AVANTI. Birmingham. AL) or. in the case of polyphosphoinositides. were prepared according to HENDRICKSOX & BALLOU (1964) .
Hydrolysis of phospholipids was studied with previously extracted 3'P-labelled lipids. The lipid extract was dried under N, and suspended in 40 ~M -T~S -C I (pH 7.4) with a Polytron PT 10-35 (Brinkman 1nstr.I. Portions of this suspension were incubated at 37-C with the nerve ending fraction in (final concentrations) 80 mM-Tris-CI pH 7.4. I mM-NaF, and 1 mM-MgCi,. in a total vol of 0.5 ml. Incubations were terminated and lipids extracted as above.
For studies of physicochemical interactions between neomycin and the polyphosphoinositides. the lipids were prepared by chromatography on DEAE~ellulose (HEY DRICKSON & BALLOU, 1964 ) from bovine brain obtained from a local slaughterhouse. The composition of the lipid fraction used in these experiments was estimated after TLC to be 800/: phosphatidylinositol diphosphate and 20"" phosphatidylinositol phosphate with only traces of other phospholipids. Dispersions of this lipid fraction in 20 mM-Tris4 (pH 7.4) were mixed with increasing concentrations of neomycin and turbidity was determined in a spectrophotometer at 520 nm (FEINSTEIS. 1964) after a stable absorbance was reached. Dilutions of the lipid suspension with water served as blanks. Neomycin does not absorb at 520nm. For pH titrations with neomycin. the lipids were suspended in water and the suspension as well as the drug were adjusted with HCI or NaOH to pH 6.10 & 0.03. Changes of pH of the lipid dispersion upon addition of neomxcin were monitored with a pH meter.
[ Data presented are generally averages of at least duplicate determinations with variability less than 10"". 
RESULTS

Lahellirig qf' subcellular fractions
Fractions obtained by differential and density gradient centrifugation were incubated with [y-32P] T h e time course of labelling ( Fig. 1) showed linearity of 3'P-incorporation for somewhat less than 5 min. The effect of I Ow4 M-neomycin on polyphosphoinositide labelling was evident at all times, while n o influence was observed on phosphatidic acid labelling.
Eflect of rwoniycin
T h e changes of '*P-incorporation into the polyphosphoinositides depend o n the concentration of The fractions were incubated with IOpCi ':P-ATP for 5 min as described in 'Methods'. Neomycin was ~O -' M . neomycin (Fig. 2) . Both the decrease in 32P-phosphatidylinositol diphosphate and the increase in 32P-phosphatidylinositol phosphate are clearly evident at 10-4~-neomycin and in some cases-as in the experiment presented-small effects could be observed at M drug.
The incubation medium was similar to that of KAI et ul. (1968) and had been modified to promote the highest rate of 32P-incorporation into the polyphosphoinositides. Variation of its composition did not significantly influence the effect of neomycin except when changes in the magnesium concentration (Table   2 ) or in pH (Fig. 3) were made. With increasing Mg2+, the basal rate of labelling of phosphatidylinositol phosphate was enhanced about six-fold while the relative effect of neomycin (percentage stimulation) was decreased. Phosphatidylinositol diphosphate also responded to Mgz+, and neomycin which inhibited its labelling at higher Mg2+ slightly stimulated it at 1 mM-MgC1,.
A rather broad pH optimum is observed for the 32P-incorporation into phosphatidylinositol phos- of the maximal rate. In contrast, stimulation by neomycin is essentially abolished at pH 8.5 and 9.0.
Compurison with other drugs
The action of neomycin was compared with that of a number of other drugs (Table 3) .
Tobramycin, gentamicin and kanamycin. which are desoxystreptamine antibiotics, as is neomycin. stimulated labelling of phosphatidylinositol phosphate. Streptomycin an aminoglycoside of the streptidine group decreased 3'P-phosphatidylinositol diphosphate (Table 3 , Exp. A). Of the neomycin fragments (Exp. B) only neamine was found to increase phosphatidylinositol labelling. The magnitude was less than with the intact antibiotic, but a stimulation was consistently observed in a number of experiments. Other inhibitors of bacterial protein synthesis, such as puromycin and clindamycin or local anaesthetics (Exp. C) were ineffective. The polyamine spermine, however, and the polyamino acid poly-L-lysine (Exp. D) altered polyphosphoinositide labelling similarly to neomycin. In most of these experiments, [y-32P]ATP was measured at the end of the incubation time. About 307, of the intially added ATP was usually recovered, and M-neomycin decreased this amount by about 10% (i.e. 25-27"/, recovered). The increased hydrolysis of ATP in the presence of neomycin may account for some of the drug effect on phosphatidic acid labelling. A consistent decrease of [ 32P]phosphatidate could only be observed at higher drug concentrations. In contrast to neomycin, poly-L-lysine inhibited the hydrolysis of ATP slightly (about 15%). Other drugs did not show effects that exceeded loo/;. (Fig. 4) . There was n o nonenzymatic breakdown under these conditions. Neomycin was inhibitory a t concentrations of lo-' M o r higher (Fig. 5 ).
In these experiments where n known amount of 32P-polyphosphoinositides was added to the incubation medium,.no influence of neomycin on the recov- 
Drugllipid iiiteractioiis
Low concentrations of neomycin increased the turbidity of buffered aqueous dispersions of polyphosphoinositides (Fig. 6) . At a lipid concentration of PhIP, A-A PhIP,; Symbols at the left ordinate: control incubation without drug. Half closed symbols at the right ordinate: "P-lipid present at the start of the incubation: fully closed symbols: same. but extraction in the presence of ery could be detected (Fig. 5) .
I 0-' M-neomycin 0.4 mM-lipid-phosphate, 40 pM-neomycin produced maximal turbidity. The same concentration of the drug decreased the pH of an unbuffered aqueous polyphosphoinositide suspension (0.2 m-lipid-phosphate) from 6.1 to 5.6 indicating an ionic exchange between the hydrogen of the lipid phosphate and neomycin.
DISCUSSION
The rapid hbekng of phosphatidylinositol phosphate and phosphatidylinositol diphosphate in brain subcellular fractions in uitro by the reactions (COLOD- ZIN & KENNEDY, 1965; KAI et al., 1968) :
makes this an easily accessible system for the study of polyphosphoinositide metabolism. In this study we see a pronounced stimulation of 32P-incorporation into phosphatidylinositol phosphate and a decrease of incorporation into phosphatidylinositol diphosphate in the presence of neomycin. Labelling of phosphatidate, the only other highly labelled lipid, remained largely unaffected at low drug concentrations.
The susceptibility to neomycin did not seem to be associated with a particular subcellular fraction. The nerve ending fraction was selected for further studies on the basis of its efficiency of 32P-incorporation into et al., 1966, 1968) , and was confirmed in our experiments. Low concentrations of Mg2 + appeared to favor a higher (percentage) stimulation of phosphatidylinositol phosphate labelling by neomycin. but the stimulatory effect on the diphosphate was inconsistent in a number of experiments. Five mM-Mg2+ promoted almost maximal labelling of phosphatidylinositol diphosphate and a pronounced and reproducible effect of the drug on both polyphosphoinositides. Variation of the pH of the incubation medium significantly changed the antibiotic action. With increasing pH, basal labelling of phosphatidylinositol phosphate is only slightly affected while the stimulation by neomycin is reduced. At pH 9, no drug effect is evident. Since the apparent pK of neomycin is approx. 8.2 (KOEPSELL & FORD, 1958) this indicates that the cationic form of the antibiotic is the active species in changing the lipid labelling.
It appears unusual that labelling of phosphatidylinositol phosphate and diphosphate are affected in opposite 'ways. A number of previous studies have indicated that both lipids show a similar response to drugs or experimental conditions that change their turnover (WHITE et al.. 1974; SCHACHT & AGFUNOFF, 1972a, b; LLOYD et al., 1972) . Since phosphatidylinositol kinase and phosphatidylinositol phosphate kinase are distinct enzymes, a differential action by neomycin is not surprising. Inhibition of the latter enzyme might explain all of the observed effects on 32P-incorporation. A stimulation of phosphatidylinositol diphosphate phosphomonesterase might also be considered to explain the incorporation studies, but this mechanism is contradicted by the inhibition of polyphosphoinositide breakdown evident in experiments in which neomycin was added to previously labelled lipids. Examination of the action of a number of other drugs suggests. however, a third mechanism. The neomycin effect is class-specific. It is shared by structurally-related antibiotics of the aminoglycoside group, but not by other antibacterial agents or local anesthetics. The latter are also known to interact with phospholipids. EICHBERG & HAUSER (1 974) reported a stimulation by cocaine and lidocaine of 32Pi incorporation into acidic phospholipids in the intact pineal gland. FEINSTEIN (1964) described the formation of ionic complexes between local anaesthetics and phospholipids. In this study, only polyamines produce changes in lipid labelling like those produced by neomycin. Poly-L-lysine has been reported to form insoluble mixed complexes with Me (11) ions and phosphatidylinositol diphosphate (FULLINGTON & HEN-DRICKSON, 1966 ) and we suggest a similar action for neomycin. The turbidity experiment confirms the formation of a complex between polyphosphoinositides and the drug. The displacement of H + from the polyphosphoinositides indicates that the complex is based on ionic interactions, which is supported by the fact that the neomycin cation is required for the effect on lipid labelling.
Our study then suggests that the binding of neomycin to the polyphosphoinositides renders these lipids unavailable as substrates for the phosphoesterases and for phosphatidylinositol kinase. This assumption of a complex formation between neomycin and the polyphosphoinositides is sufficient to explain the observed it7 iiitro effects as well as the in viuo neomycin action on inner ear tissues as we have previously speculated (ORSULAKOVA et a/.. 1976) . Cellular toxicity of polycations including poly-~-lysine is documented for the rat kidney (SEILER, et al., 1975) . Ototoxic effects of polycations have, to our knowledge. not been reported. Preliminary studies (Nuttall & Schacht, unpublished) indicate that spermine as well as poly-L-lysine decrease the cochlear microphonic potential when administered by cochlear perfusion. Thus, the ototoxicity of neomycin may well be due to the polyamine character of the drug.
It should be expected that neomycin will also bind to other acidic phospholipids. This question still has to be examined. but this study indicates some preferential action on polyphosphoinositides at low drug concentrations. Moreover, our in Liuo studies of neomycin toxicity in the inner ear (ORSULAKOVA et a/., 1976) and recently in the kidney (SCHIBECI & SCHACHT, 1976) demonstrated a neomycin effect on the polyphosphoinositides but not on other lipids. Further investigations of drugilipid interactions in artificial membranes (LODHI et a/., 1976) should help to elucidate this point. Knowledge of the specificity of the neomycin action and of its physiological effects in uivo may contribute to our understanding of the functional significance of the polyphosphoinositides.
